Melanie Cobb, Ph.D.
About Melanie Cobb, Ph.D.
Melanie Cobb, Ph.D., is a Senior Scientist at Verge Genomics with a strong background in neurodegenerative disease research and advanced imaging techniques. She has held various research and teaching positions at institutions such as UC Davis and Gladstone Institutes, and she possesses extensive experience in mentorship and project management.
Work at Verge Genomics
Melanie Cobb, Ph.D., has been serving as a Senior Scientist at Verge Genomics since 2021. In this role, she focuses on advancing research related to neurodegenerative diseases. Her work involves applying her expertise in biochemistry and molecular biology to develop innovative solutions for understanding and treating these conditions.
Education and Expertise
Melanie Cobb earned her Doctor of Philosophy (Ph.D.) in Biochemistry, Molecular Cell, and Developmental Biology from the University of California, Davis, where she studied from 2009 to 2015. Prior to this, she completed her Bachelor of Science (B.S.) in Biochemistry with a minor in biology at Western Washington University from 2005 to 2009. Her educational background provides a strong foundation for her expertise in human iPSC culture, neuronal differentiation, and advanced imaging techniques.
Background
Melanie Cobb has a diverse professional background in scientific research. She began her career as a Biochemistry Undergraduate Research Assistant at Western Washington University from 2007 to 2009. She then worked as a Graduate Teaching Assistant and Graduate Student Researcher at UC Davis between 2011 and 2015, gaining valuable experience in mentorship and project management. Following her time at UC Davis, she worked as a Staff Research Scientist at Gladstone Institutes from 2016 to 2021.
Achievements
Throughout her career, Melanie Cobb has developed a strong skill set in image analysis, molecular biology, and biochemistry. She has experience with advanced imaging techniques, including live high-throughput robotic microscopy, confocal microscopy, and TIRF. Her research has a strong focus on neurodegenerative diseases, contributing to the understanding and potential treatments for these conditions.